This is a special drug use surveillance on long-term use of alogliptin, designed to investigate the safety and efficacy of treatment with alogliptin in patients with mild type 2 diabetes mellitus in the routine clinical setting.~Participants will be patients with mild type 2 diabetes mellitus. The planned sample size is 20,000.~The usual adult dosage for oral use is 1 alogliptin tablet (25 mg of alogliptin) once daily.
The purpose of this study is to examine the safety and efficacy of long-term treatment with alogliptin (Nesina) in patients with mild type 2 diabetes mellitus in the routine clinical setting.